← Back to headlines



Ozempic Is About to Go Generic in India, China and Canada
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
19 Mar, 04:00 — 19 Mar, 04:00
Related Stories

4.9 million children died before age five in 2024, says UN
just now
Stay Well: ?I can’t shift weight from my legs and hips – could it be lipoedema?
19m ago

Πόσα λεπτά ενδυνάμωσης χρειάζονται οι άνω των 50 ετών την εβδομάδα, σύμφωνα με ειδικούς
19m ago
Children with life-threatening food allergies ‘forgotten’, parents tell TDs
19m ago